Log In
Print this Print this

GSK961081 (961081) (formerly TD-5959)

  Manage Alerts
Collapse Summary General Information
Company Theravance Inc.
DescriptionBifunctional muscarinic receptor antagonist and beta 2 agonist (MABA)
Molecular Target Muscarinic receptor ; Adrenergic receptor beta 2 (ADRB2)
Mechanism of ActionMuscarinic receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationChronic obstructive pulmonary disease (COPD)
Indication DetailsTreat chronic obstructive pulmonary disease (COPD)
Regulatory Designation
Partner GlaxoSmithKline plc; Theravance Biopharma Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today